Enabled Therapeutics
PrivateLast Round
Grant
Oct 12, 2018
Company Overview
Enabled Therapeutics is a biotechnology company developing a new class of prodrugs, known as Captons, to address acute and progressive conditions of the central nervous system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enabled Therapeutics Comparables
Compare Enabled Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Theralase Technologies Inc. | 78% | |
| ImPact Biotech | 71% | |
| Prokarium | 70% |
Enabled Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 12, 2018 |
Key People
Founding team and executive leadership
Enabled Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors grew 738% MoM, reaching 1.5K.
- Feb 5, 2026
Monthly visitors grew 108% MoM.
Enabled Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Enabled Therapeutics's valuation, stock price, and market status.
Is Enabled Therapeutics a public or private company?
Enabled Therapeutics is a private company.
What is the current stock price of Enabled Therapeutics?
Enabled Therapeutics is a private company with no public stock price. Caplight tracks Enabled Therapeutics's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Enabled Therapeutics worth (valuation)?
Valuation information for Enabled Therapeutics is not publicly available.
Can I buy Enabled Therapeutics stock?
Enabled Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Enabled Therapeutics's last funding round?
Enabled Therapeutics's most recent funding round was Grant on October 12, 2018.
Who are the main investors in Enabled Therapeutics?
Key investors in Enabled Therapeutics include NIH RADx.
Will Enabled Therapeutics IPO soon?
No public IPO plans have been announced for Enabled Therapeutics.
How can I track Enabled Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Enabled Therapeutics's secondary market activity and sign up for updates.